Retour au classement

MetLife Inc (MET)

Juste valeur
Financial ServicesInsurance - LifeUnited States

Fondamental

46

Prix

$93.35

Capitalisation boursière

$60.89B

Partie 1 · Ce que vaut l'entreprise

Vue d'ensemble

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

Compare

Generated on 19 septembre 2026 with claude-haiku-4-5 — shared with all users

P/E: 10.3Score: 63Market cap: $40.05B

Prudential bids against MetLife for the same large-employer group life and disability contracts and for the same pension risk transfer and institutional retirement mandates in the United States, often splitting the biggest deals between the two.

P/E: 20.4Score: 55Market cap: $14.42B

Unum sells the same workplace benefits package — group disability, group life and voluntary coverages — to the same US employers and brokers that MetLife's Group Benefits segment serves.

P/E: 7.9Score: 83Market cap: $34.14B

The Hartford's Employee Benefits arm competes head-on with MetLife for group life, disability and absence-management programmes at US employers of every size.

P/E: 12.1Score: 65Market cap: $56.93B

Aflac competes with MetLife in the same two markets that matter most to it: voluntary supplemental benefits sold at the US workplace, and life and health policies sold to Japanese households.

P/E: 16.1Score: 59Market cap: $24.66B

Principal chases the same small and mid-sized employers for group benefits and workplace retirement plans, and competes with MetLife Investment Management for institutional asset mandates.

Lincoln National CorporationLNC

Lincoln's Group Protection unit and its individual life and annuity lines target the same US employers and retail savers that MetLife pursues.

Bilan & Liquidités

Chiffre d'affaires

$2.68B

12 derniers mois (au 30/06/2026)

Résultat net

$3.63B

12 derniers mois (au 30/06/2026)

Flux de trésorerie libre

-

Capitaux propres totaux

$28.40B

Passif total

$716.25B

Ratio de liquidité général

0.19

Couverture des intérêts

8.48

Dette/EBITDA

2.43

Bénéfice par action

Chiffre d'affaires & Résultat net

Flux de trésorerie libre

Décomposition du résultat

État historique

Marges dans le temps

La dette dans le temps

Le poids de la dette

Grille de la croissance

Croissance — Chiffre d'affaires

Estimation de la juste valeur

AssuranceJustement valorisé

Juste valeur

$78.06

Prix actuel

$93.35

Marge de sécurité

-19.6%

Fourchette de juste valeur

$56.93 - $99.20

Écart entre les méthodes de valorisation utilisées, pas un intervalle de confiance calibré statistiquement.

Méthodes d'estimation

Objectif de cours des analystes:$105.75
Flux de trésorerie actualisés (DCF):Non applicable à ce type d'entreprise
Multiple de résultat (P/E):$46.32
Formule de croissance de Graham:Non applicable à ce type d'entreprise
Valeur de la capacité bénéficiaire (EPV):Non applicable à ce type d'entreprise
P/B justifié:$79.02
Actualisation des dividendes (Gordon):$53.74
P/FFO, les fonds provenant de l'exploitation:Non applicable à ce type d'entreprise
Bénéfices de milieu de cycle:Non applicable à ce type d'entreprise
Multiple sur le chiffre d'affaires:Non applicable à ce type d'entreprise
Consensus des analystes:Acheter (17B / 7H / 0S)
Dernière surprise sur les résultats:+4.93%

Indicateurs de valorisation

Ratio P/E

18.00

ROE

11.9%

Ratio P/B

2.18

P/FCF

-

Marge brute

-

ROIC

-

Radar de rentabilité

Création de valeur (avantage concurrentiel)

ROIC

-

WACC

7.9%

ROIC − WACC

-

Critères d'analyse fondamentale

Réussi (11)

  • Price CAGR 7.30%
  • P/B Ratio 2.18
  • Operating Margin 245.0%
  • Interest Coverage
  • Debt/EBITDA
  • Low reliance on intangibles
  • ROE 12.9%
  • Analyst Consensus 71% Buy
  • Earnings Surprise avg 5.2%
  • Earnings Quality (OCF/NI) 4.29
  • Share Dilution -3.7%

Échoué (9)

  • EPS shows upward trend
  • EPS CAGR -0.84%
  • Debt/Equity ratio
  • Return on Tangible Assets
  • Price below Graham Number
  • DCF valuation (Unknown)
  • Revenue Growth 5Y 2.6%
  • Net Margin Trend 135.3% vs 184.4%
  • Piotroski F-Score 4/9

Indisponible (8)

  • ROIC NaN%
  • Gross Margin NaN%
  • P/FCF NaN
  • Dividend Payout NaN%
  • Positive Free Cash Flow
  • CapEx intensity
  • Current Ratio
  • PEG Ratio (need PE > 0 and growth > 0)

Score F de Piotroski

4/9

Signaux mixtes : certains domaines nécessitent attention

score
criteria

Qualité des bénéfices

4.29

Qualité élevée : bénéfices soutenus par la trésorerie

Dilution du capital

-3.7%

Rachat d'actions. Favorable aux actionnaires

Participations institutionnelles

Gouvernance

Équipe dirigeante

NomTitreÂge
Mr. Michel Abbas KhalafCEO, President & Director-
Mr. Bill PappasExecutive VP and Head of Global Technology & Operations55
Ms. Marlene Beverly DebelExecutive VP, Chief Risk Officer & Head of Insurance Investments58
Mr. Ramy TadrosRegional President of U.S. Business & Head of MetLife Holdings49
Mr. John Arthur HallSenior VP, Head of Investor Relations & Executive VP and Treasurer-
Ms. Monica M. CurtisExecutive VP, Chief Legal Officer & Head of Government Relations42
Ms. Jane SlusarkChief Communications Officer-
Mr. Michael RobertsExecutive VP & Chief Marketing Officer-
Ms. Shurawl SibbliesExecutive VP & Chief Human Resources Officer53
Mr. Randy StramSenior Vice President of Group Benefits-

Risque d'audit

4

Risque du conseil

3

Risque de rémunération

1

Risque droits des actionnaires

9

Partie 2 · Le prix et le moment d'entrer

Cette partie ne dit pas si l'entreprise vaut la peine : elle aide à choisir quand l'acheter, une fois que les fondamentaux vous ont convaincu. À l'intérieur : analyse technique, potentiel, baisses historiques, exposition gamma.

Documents

  • Rapport annuel (10-K)

    Un aperçu annuel de l'activité, des résultats financiers et des risques de l'entreprise.

    Déposé le 2026-02-19

    Voir le document
  • Rapport trimestriel (10-Q)

    Une mise à jour de la performance financière des trois derniers mois.

    Déposé le 2026-08-06

    Voir le document
  • Rapport d'événement important (8-K)

    Un avis concernant un événement important, comme un changement de direction ou une annonce majeure.

    Déposé le 2026-09-24

    Voir le document

via SEC EDGAR

Historique des résultats

via SEC EDGAR

Latest News

Recent headlines for MET, sourced from Markets Gazette.

  • 8/5/2026POSITIVE
    MetLife’s Earnings Beat Wall Street Expectations

    MetLife Inc. reported second-quarter earnings that exceeded Wall Street's projections, driven by robust underwriting performance and significant volume growth. The company's success is attributed in part to its strategic five-year plan, initiated in late 2024, which appears to be yielding positive results. This earnings beat suggests effective operational management and strategic execution, potentially signaling a favorable outlook for the insurance giant. Investors will be watching for continued momentum and the long-term impact of the company's strategic initiatives.

  • 5/28/2026NEUTRAL
    MetLife Clashes With Ares Over Struggling Football Investment

    MetLife Inc. is reportedly in a dispute with Ares Management regarding the restructuring of Eagle Football, a holding company with stakes in several football clubs, notably Olympique Lyonnais. The disagreement centers on the financial strategy and future direction of the football investment group. While the specific details of the clash are not fully disclosed, such disputes can introduce uncertainty for investors in the involved entities. The outcome could impact the valuation and operational stability of the football assets.

  • 5/6/2026POSITIVE
    MetLife’s Improved PE Returns Lift Earnings Above Expectations

    MetLife Inc. reported first-quarter earnings that exceeded Wall Street consensus, primarily driven by enhanced returns from its private equity investments. The insurer's ability to leverage its private equity portfolio for higher gains signals effective asset management and a robust strategy in alternative investments. This performance suggests a positive outlook for MetLife's financial health and could be interpreted by investors as a sign of strong operational execution and potential for future growth, especially in its alternative asset classes.

  • 2/24/2026NEUTRAL
    Polymarket users favor Meteora in bets over ZachXBT crypto takedown

    Polymarket users have wagered over $7 million on the outcome of the investigation by prominent crypto sleuth ZachXBT, with an announcement expected on Thursday. The betting patterns indicate a preference for Meteora, suggesting many investors believe the DeFi protocol will navigate the inquiry without severe repercussions. This speculative activity underscores the high tension and uncertainty surrounding crypto projects under scrutiny, as the market attempts to anticipate the impact of potential 'takedowns'. The impending announcement will be crucial in determining the future direction of the MET token, introducing potential volatility.

via Markets Gazette